End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.016 BGN | +6.67% | -.--% | -.--% |
Valuation
Fiscal Period: December | 2019 | 2020 |
---|---|---|
Capitalization 1 | 1.04 | 1.04 |
Enterprise Value (EV) 1 | 1.018 | 0.6144 |
P/E ratio | - | -2.94 x |
Yield | - | - |
Capitalization / Revenue | 9.72 x | 4.08 x |
EV / Revenue | 9.52 x | 2.41 x |
EV / EBITDA | -3.39 x | -1.24 x |
EV / FCF | - | 2,607,601 x |
FCF Yield | - | 0% |
Price to Book | - | 0.25 x |
Nbr of stocks (in thousands) | 4,162 | 4,162 |
Reference price 2 | 0.2500 | 0.2500 |
Announcement Date | 21-05-29 | 21-05-29 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 |
---|---|---|
Net sales 1 | 0.107 | 0.255 |
EBITDA 1 | -0.3 | -0.497 |
EBIT 1 | -0.309 | -0.508 |
Operating Margin | -288.79% | -199.22% |
Earnings before Tax (EBT) 1 | -0.297 | -0.354 |
Net income 1 | -0.297 | -0.354 |
Net margin | -277.57% | -138.82% |
EPS | - | -0.0851 |
Free Cash Flow | - | 0.2356 |
FCF margin | - | 92.4% |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 21-05-29 | 21-05-29 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 |
---|---|---|
Net Debt 1 | - | - |
Net Cash position 1 | 0.02 | 0.43 |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | 0.24 |
ROE (net income / shareholders' equity) | - | -8.17% |
ROA (Net income/ Total Assets) | - | -6.93% |
Assets 1 | - | 5.109 |
Book Value Per Share | - | 1.000 |
Cash Flow per Share | - | 0.0900 |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 21-05-29 | 21-05-29 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 36.82K | |
+4.91% | 67.58B | |
+11.62% | 50.82B | |
+11.93% | 16.35B | |
+13.54% | 14.98B | |
+18.03% | 10.48B | |
+32.70% | 9.76B | |
+6.78% | 4.87B | |
+2.81% | 4.28B | |
+77.94% | 3.55B |
- Stock Market
- Equities
- OCW Stock
- Financials Orpheus Club Wellness AD